A Case of Cytokine Release Syndrome Induced by Avelumab and Axitinib Combination Therapy for Metastatic Renal Cell Carcinoma
{{output}}
Introduction: Cytokine release syndrome (CRS) is a rare immune-related adverse event of immune checkpoint inhibitors (ICIs). At present, its association with avelumab-axitinib therapy for renal cell carcinoma (RCC) has yet to be ... ...
